Pacliarc 260mg Injection
Marketer
Delarc Pharmaceuticals Private Limited
Salt Composition
Paclitaxel (260mg)
Overview Pacliarc 260mg Injection
Oncaspar 260mg Injection is a chemotherapeutic agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under your doctor's direction. Common side effects include nausea, emesis, and fatigue. Serious side effects like edema of the extremities, alopecia, and weight increase are also possible. Concomitant medications may be prescribed to mitigate these. Report unexplained bleeding or bruising, pharyngitis, oral ulcers, or pyrexia immediately. This medication can suppress blood cell production (leukopenia and anemia), increasing infection risk. Regular blood tests to monitor blood counts and hepatic function are mandatory. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all other medications, particularly anti-infectives, as drug interactions are possible. This injection is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.
Uses of Pacliarc 260mg Injection
Cancers of the breast, lung (non-small cell), and pancreas
Major Benefits of Pacliarc 260mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pacliarc 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Pacliarc 260mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Pacliarc 260mg Injection works:
Oncaspar 260mg Injection is a chemotherapy agent. Its mechanism of action involves disruption of microtubule networks, essential for cancer cell proliferation. This inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Pacliarc 260mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Pacliarc 260mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Pacliarc 260mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.
DrivingUNSAFE
The injectable medication Pacliarc 260mg can induce adverse reactions potentially impairing driving ability. While driving isn't necessarily prohibited between treatment cycles, the presence of alcohol in this formulation suggests caution regarding operating a vehicle.
KidneySAFE IF PRESCRIBED
Pacliarc 260mg Injection can be administered to patients with kidney disease without altering the dosage. While dose modification isn't typically necessary, consult your physician regarding any pre-existing kidney conditions.
LiverCAUTION
Administering Pacliarc 260mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Pacliarc 260mg Injection might be necessary. Physician consultation is advised. Pacliarc 260mg Injection is contraindicated for patients exhibiting severe liver dysfunction.
What if you forget to take Pacliarc 260mg Injection :
NA
Facts to Know About Pacliarc 260mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently
